The global market for sinus dilation devices was valued at
approximately USD 2.74 billion in 2022 and is projected to grow at a
compound annual growth rate (CAGR) of 9.6% from 2023 to 2030. Several
factors are driving this growth, including a strong preference for
minimally invasive procedures, favorable reimbursement policies, and an
increase in awareness of the advantages of balloon sinuplasty compared
to conventional treatments. Chronic sinusitis prevalence also
contributes significantly to market demand. The development of advanced
surgical techniques that replace traditional sinus procedures is
boosting market dynamics, further enhancing growth.
One major
contributor to these advancements is the introduction of cutting-edge
technologies, such as surgical laser systems in sinus surgery, which
allow for minimal tissue removal and result in fewer side effects.
Additionally, these innovations reduce the procedure time, making it
possible for many surgeries to be performed on an outpatient basis,
which is highly convenient for patients and efficient for healthcare
systems. An example of innovation in laser treatment includes the
National Health Service's (NHS) introduction in 2022 of a new laser
therapy for epilepsy patients. This treatment utilizes lasers to
precisely target and address brain areas responsible for seizures,
offering a new approach to epilepsy management that significantly
improves patient quality of life. Such technological advances serve as a
model for innovation in sinus surgery as well.
Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market
The
COVID-19 pandemic disrupted routine patient care, leading to a
temporary halt in elective surgeries and regular clinic visits to free
up healthcare resources and staff for intensive and inpatient care. This
reallocation of resources impacted treatment options for patients with
chronic rhinitis, who turned to teleconsultations and temporary care
solutions for sinus-related issues.
In Canada, for instance, the
pandemic led to a significant decline in the number of surgeries. During
the first 31 months of the pandemic, there were approximately 937,000
fewer surgeries performed (a 14% reduction) compared to pre-pandemic
levels. These figures are based on a comparison with 2019 surgery
volumes, excluding factors such as population growth. The sharpest
decline in surgeries occurred during the initial four months of the
pandemic (March to June 2020) as both scheduled and non-urgent
procedures were canceled or delayed in line with public health
guidelines.
Application Segmentation Insights:
The
adult patient segment dominated the sinus dilation device market in
2022, generating more than 65% of total revenue. This is primarily due
to the high incidence of sinusitis in adults. According to the Centers
for Disease Control and Prevention (CDC), over 28 million adults in the
U.S. have been diagnosed with sinusitis, representing approximately
11.6% of the adult population. Sinusitis, a condition in which the
air-filled spaces in the facial bones become inflamed, often results in
symptoms such as nasal congestion, facial pain, and headaches. Proper
management of sinusitis is crucial for alleviating these symptoms and
enhancing overall health.
The pediatric segment is expected to
exhibit the fastest CAGR, growing at 10.2% over the forecast period.
This growth can be attributed to an increase in sinusitis cases among
children. According to the National Center for Biotechnology Information
(NCBI), around 6-13% of children in the U.S. developed chronic or acute
rhinosinusitis by age three. Additionally, approximately 7.5% of upper
respiratory infections, commonly known as colds, can lead to acute
bacterial sinusitis (ABS) in children. ABS, however, is often
underdiagnosed in young children, making it difficult to manage in
primary care.
Several companies in the sinus dilation device
market are focusing on developing products specifically designed for
pediatric patients, further solidifying their market position. The NCBI
provides updated guidelines to help healthcare providers better diagnose
and treat bacterial sinus infections in children. These guidelines are
designed to equip doctors with information on recognizing and managing
bacterial sinus infections in young patients, which can improve outcomes
and the quality of pediatric care.
Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment